Although very limited literature is available on anti-U11/U12 autoantibodies, existing evidence strongly indicates that these antibodies are specific for SSc and associated with a severe phenotype with a poor prognosis, mostly characterized by the presence of severe ILD. The gene discussed is RNU12-2P; the disease is systemic sclerosis.